Jupiter Neurosciences, Inc.
JUNS
$0.34
-$0.01-3.29%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.58M | -2.29M | -2.25M | -1.53M | -1.53M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 193.20K | 193.20K | 191.10K | 189.00K | 82.90K |
| Total Other Non-Cash Items | 403.80K | 1.01M | 528.50K | 421.50K | 1.11M |
| Change in Net Operating Assets | -390.10K | -65.00K | 705.10K | -144.70K | -3.36M |
| Cash from Operations | -2.37M | -1.15M | -828.20K | -1.06M | -3.70M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 5.58M | -- | -- | -- | 1.50K |
| Total Debt Repaid | -146.40K | -- | -- | -- | -2.36M |
| Issuance of Common Stock | -- | -- | -- | -- | 100.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 9.73M |
| Cash from Financing | 5.43M | -- | -- | -- | 7.47M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.07M | -1.15M | -828.20K | -1.06M | 3.77M |